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Abstract
Dendrobium huoshanense is a valuable and versatile Chinese herbal medicine with the anecdotal claims of cancer prevention
and anti-inflammation. However, its immunological activities are limited to in vitro studies on a few cytokines and immune
cell functions. First, we investigated the effects of polysaccharides isolated from DH (DH-PS) on inducing a panel of
cytokines/chemokines in mice in vivo and human in vitro. We found that DH polysaccharides (DH-PS) induced TH1, TH2,
inflammatory cytokines and chemokines in mouse in vivo and human cells in vitro. Secondly, we demonstrated that DH-PS
expanded mouse splenocytes in vivo including CD4+ T cells, CD8+ T cells, B cells, NK cells, NKT cells, monocytes/
macrophages, granulocytes and regulatory T cells. Notably, DH-PS induced an anti-inflammatory molecule, IL-1ra, in mouse
and human immune cells, especially monocytes. The serum level of IL-1ra elicited by the injection of DH-PS was over 10
folds of IL-1b, suggesting that DH-PS-induced anti-inflammatory activities might over-ride the inflammatory ones mediated
by IL-1b. The signaling pathways of DH-PS-induced IL-1ra production was shown to involve ERK/ELK, p38 MAPK, PI3K and
NFkB. Finally, we observed that IL-1ra level induced by DH-PS was significantly higher than that by F3, a polysaccharide
extract isolated from another popular Chinese herbal medicine, Ganoderma lucidum. These results indicated that DH-PS
might have potential applications for ameliorating IL-1-induced pathogenic conditions.
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Introduction
Dendrobium huoshanense (DH), which is an herb of Orchidaceae
family, has been used as a traditional Chinese herbal medicine for
centuries with the anecdotal claims of cancer prevention and anti-
inflammation. Polysaccharides isolated from Dendrobium huoshanense
have been reported to induce TNF-a in peritoneal macrophages
and IFN-c in mouse splenocytes [1] and promote phagocytosis of
macrophages [2]. To date, there have been no detailed studies on
the systemic immune functions of DH-PS such as in vivo immune
cell activations, inductions of comprehensive panel of cytokines/
chemokines and anti-inflammatory molecules.
Among the cytokines, two forms of Interleukin-1 (IL-1a and IL-
1b) are thought to play an important role in inflammation and
involved in many pathological conditions including rheumatoid
arthritis [3,4]. They are produced primarily by mononuclear
phagocytes, but also by a number of other cell types including skin
keratinocytes [5]. These two cytokines are pro-inflammatory
cytokines which can stimulate the expressions of genes associated
with inflammation and autoimmune diseases. IL-1 exerts its
functions by binding to type I IL-1 receptor and induces
downstream signaling, leading to the expressions of numerous
genes resulting in inflammation [6,7,8,9]. A natural inhibitor of
IL-1 activity, designated as secreted Interleukin-1 receptor
antagonist (IL-1ra), was discovered and purified from the urine
of the patients suffering from monocytic leukemia [7,10]. IL-1ra, a
25 KD glycoprotein, is a member of IL-1 family that competes
with IL-1 for the binding to IL-1 receptor, but unlike IL-1, this
binding does not induce any signal transduction [11,12,13,14]. IL-
1ra is released in vivo during inflammation and immune-mediated
diseases [15], which is thought to limit the deleterious effects
brought by IL-1 [16,17] and shown to be effective in the treatment
of sepsis, graft-versus-host disease and rheumatoid arthritis in
animal models [18,19,20,21]. Additionally, IL-1ra (commercially
produced as ‘‘anakinra’’) has been used clinically to treat
rheumatoid arthritis in which IL-1 plays a key role [22]. Many
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types of immune cells are reported to secrete IL-1ra including
neutrophils, master cells, macrophages and monocytes [23,24,25]
and several molecules have been shown to stimulate the secretion
of IL-1ra including cytokines (IL-6 and IL-10, for example) and
natural products [13,26]. Polysaccharides isolated from Ganoderma
Lucidum, another popular Chinese herbal medicine, have been
shown to possess immune-modulating effects and reported to
induce the production of IL-1ra [27]. Although DH-PS is believed
to possess immune-modulating functions with the anecdotal claims
of cancer prevention and anti-inflammation, comprehensive
information regarding DH-PS on immune functions and its ability
to stimulate the secretion of IL-1ra is still lacking.
In the present study, we evaluated the immune-modulating
effects of DH-PS by investigating the profiles and kinetics of
cytokine productions, as well as expansions and activations of
immune cells induced by DH-PS in both human and mouse
system. Moreover, we demonstrated that DH-PS induced IL-1ra
production through the activation of PI3K, p38 MAPK and
NFkB. Finally, we compared the IL-1ra production induced by
DH-PS and F3, the polysaccharide extract from another popular
Chinese herbal medicine, Ganoderma lucidum.
Results
DH-PS induced the secretions of multiple cytokines and
chemokines in vivo
In order to understand the immunological activities of DH-PS,
we investigated the profiles of cytokines and chemokines induced
by DH-PS in mice. BALB/c mice (n = 3 for DH-PS and phosphate
buffered saline (PBS) group) were injected intraperitoneally (IP)
with DH-PS (300 mg/mouse) in PBS or PBS only and the sera
were collected at 0 (before injection), 2 and 18 hrs after the
injection of DH-PS for the detection of cytokines and chemokines,
which were quantified by Beadlyte Mouse 21-plex Cytokine
Detection system and ELISA kits (for IL-1ra). Compared with PBS
group shown in Figure 1, the increase of TNF-a, IL-12 p40, IL-6,
IL-10 and RANTES were observed at 2 hrs, along with robust
inductions of KC, MCP-1 and MIP-1b. An apparent increase in
IL-1b at 2 hrs was noted but it did not reach statistical significance.
These results suggested that DH-PS induced Th1 (IL-12 p40), Th2
(IL-6, IL-10), inflammatory cytokines (TNF-a) and chemokines
(KC, RANTES, MCP-1, MIP-1b), which might further modulate
the downstream activations of immune cells. Furthermore, an anti-
inflammatory molecule, IL-1ra, was increased from 465 to
4199 pg/ml (,9 folds of PBS control group) at 2 hrs. This
indicated that the amounts of IL-1ra induced were 10 folds more
than IL-1b (increased from 144 to 397 pg/ml, ,1.6 folds of PBS
control group), suggesting that DH-PS-induced IL-1ra might over-
ride the activity induced by IL-1b.
DH-PS expanded and activated subpopulations of
immune cells in vivo
In order to investigate the effects of DH-PS on immune cells, we
further analyzed whether DH-PS expanded and/or activated the
subpopulations of mouse splenocytes. BALB/c mice (n = 3 for
DH-PS and PBS group) were injected intraperitoneally with DH-
PS (100 mg or 300 mg) or PBS (DH-PS= 0) only and sacrificed at
72 hrs for the harvest of splenocytes. Cells were counted and
analyzed for markers characteristic of specific subpopulations of
splenocytes by flow cytometry to determine the expansions/
activations of various immune effector cells. As shown in
Figure 2A, in comparison with PBS control group, the number
of splenocytes was increased after the administration of DH-PS in
a dose-dependent manner. Subpopulations of splenocytes exam-
ined included innate immune cells such as natural killer cells (NK-
1.1+/CD32)/activated natural killer cells (NK-1.1+/CD32/
CD69+), natural killer T cells (NK-1.1+/CD3+)/activated natural
killer T cells (NK-1.1+/CD3+/CD69+), regulatory T cells (CD4+/
CD25+/Foxp3+), granulocytes (Ly6G+), monocytes and macro-
phages (CD11b+) and dendritic cells (CD11c+/CD80+/CD86+)
and adaptive immune cells such as B cells (B220+CD23+)/
activated B cells (B220+CD23+CD69+), CD4+ T cells
(CD3+CD4+)/activated CD4+ T cells (CD3+CD4+CD69+),
CD8+ T cells (CD3+CD8+)/activated CD8+ T cells
(CD3+CD8+CD69+). Overall, DH-PS induced modest increases
(up to 2.08 fold) in all subpopulations examined. Compared with
PBS group, we found that DH-PS induced 1.3 and 1.7 fold
increases of NK cells at 100 mg and 300 mg, respectively. A mild
increase (1.24 folds) of activated NK cells was also observed at
300 mg (Fig.2B). DH-PS induced 1.3 and 1.6 fold increases of
NKT cells at 100 mg and 300 mg, respectively. An increase (1.37
folds) of activated NKT cells was also observed at 300 mg (Fig.2C).
DH-PS also induced 1.55 and 1.79 fold rise of regulatory T cells at
100 mg and 300 mg, respectively (Fig.2D) and a trend in increases
of granulocytes and monocytes/macrophages (Fig.2E, F). Howev-
er, there was no significant effect of DH-PS on dendritic cells
(Fig.2G). For the adaptive immune cells, DH-PS induced 1.27 and
1.53 fold increases of B cells and 2.08 and 1.91 fold rise of
activated B cells at 100 mg and 300 mg, respectively (Fig.2H). As to
CD4+ T cells (Fig.2I), DH-PS induced 1.32 and 1.56 fold increases
at 100 mg and 300 mg, respectively. Activated CD4+ T cells were
also augmented to 1.64 and 1.98 folds, respectively. For CD8+ T
cells (Fig.2J), DH-PS induced 1.22 and 1.50 fold increases and
activated CD8+ T cells to 1.63 and 1.96 folds at 100 mg and
300 mg, respectively. These findings indicated that DH-PS
modestly expanded and/or activated many types of immune cells
in mice.
DH-PS induced the productions of multiple cytokines
and chemokines in human immune cells
We next investigated the effects of DH-PS on primary human
immune cells. Human peripheral blood mononuclear cells
(PBMC) were isolated from three healthy donors and cultured
with DH-PS (50 mg/ml) or PBS as control for 18 hrs. Supernatants
were collected for the measurements of cytokines, chemokines and
IL-1ra. As shown in Figure 3, TH1 (IL-12 p40), TH2 (IL-6, IL-10),
inflammatory cytokines (IL-1a, IL-1b TNF-a) and chemokines
(MIP-1a) were induced in PBMC by DH-PS. A growth factor
GM-CSF was also augmented by DH-PS. Consistent with mouse
data, IL-1ra was induced by DH-PS in human PBMC. Since
PBMC contained a mixture of immune cells, we next focused on
the DH-PS-induced effects on CD14+ cells which were reported to
play a key role in rheumatoid arthritis. CD14+ cells were isolated
from PBMC and cultured with DH-PS (50 mg/ml) or PBS as
control for 18 hrs. The supernatants were collected for the
measurements of cytokines, chemokines and IL-1ra. As shown in
Figure 4, there were significant increases in IL-1a, IL-1b and IL-
1ra along with IL-12 p40, IL-6, TNF-a, IL-10, GM-CSF,
RANTES, MCP-1 and MIP-1a. Moreover, DH-PS boosted IL-
1ra production from basal levels of (135–196) to 1427, 837 and
1264 (pg/ml) and induced IL-1b from 7 to 55, 24 and 70 (pg/ml)
in CD14+ cells of 3 healthy donors. Thus the calculated IL-1ra/
IL-1b ratios were 25.9, 34.8 and 18.1, suggesting that the IL-1ra
induced by DH-PS might over-ride IL-1b activities. These data
indicated that DH-PS induced Th1, Th2, inflammatory cytokines,
chemokines and an anti-inflammatory molecule, IL-1ra, with an
overall anti-IL-1b activity and the pattern of cytokines and
chemokines induced by DH-PS was similar to the results in mice.
DH-PS Induced IL-1ra Production in Monocyte
PLOS ONE | www.plosone.org 2 April 2014 | Volume 9 | Issue 4 | e94040
Dose-dependency of IL-1ra induction by DH-PS in mice
As a potent antagonist of the biological functions of IL-1, IL-1ra
has been in clinical use for the treatment of IL-1-induced
pathogenic conditions including rheumatoid arthritis. To further
delineate the kinetics and dose effects of DH-PS on IL-1ra
production, BALB/c mice (n = 3 for each group) were injected
intraperitoneally with DH-PS (100 or 300 mg/mouse) or PBS.
Sera were collected at 0 (before injection), 2 and 18 hours for the
measurements of IL-1ra. As shown in Figure 5, IL-1ra was
significantly increased in a dose-dependent manner at 2 hrs after
the administration of DH-PS, as compared to PBS group, and
declined rapidly to basal level at 18 hrs.
DH-PS induced IL-1ra secretion in human monocytes but
not neutrophils
Next, we investigated the effects of DH-PS on IL-1ra secretion
in human primary immune cells. At the concentrations ranging
from 0 (use of PBS as control) to 200 mg/ml, DH-PS induced dose-
dependent increases of IL-1ra production in PBMC, reaching the
maximal level of ,10 fold rise at 100 mg/ml (Fig.6A). Since
monocytes and neutrophils were two types of immune cells
reported to produce IL-1ra upon stimulations [24], we further
investigated the responses of the two types of cells stimulated by
DH-PS. CD14+ cells were isolated from PBMC and cultured with
increasing concentrations of DH-PS ranging from 0 (use of PBS as
control) to 100 mg/ml for 18 hrs. As shown in Figure 6B, DH-PS
induced CD14+ cells to produce IL-1ra dose-dependently,
Figure 1. DH-PS elicited the productions of cytokines and chemokines in vivo. BALB/c mice (n = 3 for DH-PS and PBS group) were injected
intraperitoneally with DH-PS (300 mg/mouse) or PBS only. Sera collected at 0 (before injection), 2 and 18 hours were used for the measurements of
cytokines and chemokines. Y-axis represented the mean concentrations (Conc.) of cytokines/chemokines with error bars showing the standard
deviation of three mice. Statistically significant difference: * compared with PBS-treated group, p,0.01. # compared with PBS-treated group,
p,0.001.
doi:10.1371/journal.pone.0094040.g001
DH-PS Induced IL-1ra Production in Monocyte
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reaching the maximal level of ,6 fold increases at 100 mg/ml.
However, neutrophils showed no significant production of IL-1ra
with the stimulation of DH-PS for 3 or 24 hrs (Fig.6C). Taken
together, DH-PS stimulated IL-1ra production in human CD14+
cells but not neutrophils.
Next, we used a human monocytic cell line, THP-1, as our
model for more detailed studies. THP-1 cells were seeded at
different densities and cultured with increasing concentrations of
DH-PS for 18 hr. As shown in Figure 7A, the production of IL-1ra
was dose-dependent starting from 1 mg/ml. The kinetics of IL-1ra
induced by DH-PS was examined in THP-1 cells cultured at
26106 cells/ml with DH-PS (100 mg/ml) or PBS as control. The
supernatants were collected for IL-1ra measurement at various
time points. As shown in Figure 7B, DH-PS induced 2.2 fold
increases of IL-1ra production at 3 hrs and the induction steadily
increased to 72 hrs. The kinetics of IL-1ra induced by DH-PS at
the RNA level was also examined by RT-PCR. As shown in
Figure 7C, IL-1ra mRNA became detectable at 1 hr and appeared
to reach the plateau at 12 hrs. In addition to the induction of IL-
1ra in THP-1 cells, there was a dose-dependent increase in cell
Figure 2. DH-PS expanded subpopulations of splenocytes. BALB/c mice (n = 3 for DH-PS and PBS group) were injected intraperitoneally with
DH-PS (100 mg or 300 mg) or PBS only (DH-PS = 0) and sacrificed at 72 hrs for the harvest of splenocytes. Cell populations were characterized by the
following markers: NK cells (NK-1.1+CD32), activated NK cells (NK-1.1+CD32CD69+), NKT cells (NK-1.1+CD3+), activated NKT cells (NK-1.1+CD3+CD69+),
regulatory T cells (CD4+CD25+FOXP3+), granulocytes (Ly6G+), monocytes and macrophages (CD11b+), dendritic cells (CD11c+), activated dendritic
cells (CD11C+CD80+CD86+), B cells (B220+CD23+), activated B cells (B220+CD23+CD69+), CD4+ T cells (CD3+CD4+), activated CD4+ T cells
(CD3+CD4+CD69+), CD8+ T cells (CD3+CD8+) and activated CD8+ T cells (CD3+CD8+CD69+). Results were presented as mean values with error bars
showing the standard deviation of three mice. Results were converted to log value before the determination of statistical significance. Statistically
significant difference: * compared with PBS-treated group, p,0.05. # compared with PBS-treated group, p,0.01.
doi:10.1371/journal.pone.0094040.g002
DH-PS Induced IL-1ra Production in Monocyte
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number upon incubation with increasing concentrations of DH-PS
(up to 1.5 folds), suggesting that DH-PS might directly promote
cell expansions besides the stimulation of cytokine secretions
(Fig.S2).
Intracellular signaling of DH-PS-induced IL-1ra
production in monocytes
To investigate DH-PS-induced intracellular signaling mediating
IL-1ra expression, we utilized inhibitors for various kinases
including ERK/ELK (PD98059), JNK (SP600125), p38 MAPK
(SB203580), PI3K (Ly294002) and NFkB inhibitors (Helenalin
and MG132) at concentrations showing no toxicity to cells
(Fig.S1). THP-1 cells (Fig.8A) or human CD14+ cells (Fig.8B) were
pretreated with these inhibitors at increasing concentrations or
DMSO as control for 60 minutes and cultured with DH-PS
(100 mg/ml) for another 18 hrs. In both THP-1 and human
CD14+ cells, the inhibitors of ERK/ELK, JNK, p38 MAPK,
PI3K and NFkB diminished the secretion of IL-1ra in a dose-
dependent manner. In order to determine whether these signaling
molecules regulated the IL-1ra production at transcriptional level,
THP-1 cells were pretreated with the inhibitors at indicated
concentrations or DMSO as control for 60 minutes and cultured
with DH-PS (100 mg/ml) for another 12 hrs. The mRNA
expression level of IL-1ra was examined by RT-PCR. The results
showed that inhibitors of ERK/ELK, PI3K and NFkB (Helenalin)
dampened IL-1ra mRNA expression (Fig.8C), which was consis-
tent with the results of IL-1ra production in protein level (Fig.8A).
On the other hand, the inhibitors of JNK and p38 MAPK had no
significant effects on mRNA expression.
DH-PS induced larger amounts of IL-1ra than F3 (G.
lucidum)
Ganoderma lucidum is a Chinese herbal medicine that has been
used for centries to treat a variety of diseases including
inflammation and cancer [28]. F3, the polysaccharide extract of
Ganoderma lucidum has been reported to possess immune-modulat-
ing functions and induced IL-1ra in mice [27]. Therefore, we
examined the induction of IL-1ra by DH-PS or F3 in human
CD14+ cells and THP-1 cells and the kinetics of IL-1ra mRNA
expression in THP-1 cells. Human CD14+ cells (Fig.9A) and THP-
1 cells (Fig.9C) were cultured with increasing concentrations of
DH-PS or F3 for 18 hrs. The kinetics of IL-1ra secretion in CD14+
cells upon the treatments of DH-PS and F3 (100 mg/ml) was also
measured (Fig.9B). As shown in Figure 9A and 9C, both DH-PS
and F3 induced dose-dependent productions of IL-1ra, but the
maximal level induced by DH-PS was 2.2 folds of that by F3 in
both CD14+ and THP-1 cells. As to the kinetics of IL-1ra
induction in CD14+ cells, DH-PS elicited faster and larger
amounts of IL-1ra than F3 with 1.4, 1.7 and 2.0 folds at 3, 24
and 48 hrs, respectively, reaching 2.1 folds at 72 hrs (Fig.9B). We
also assessed the kinetics of IL-1ra mRNA expression in THP-1
cells cultured with DH-PS or F3. As shown in Figure 9D, DH-PS
Figure 3. DH-PS elicited the productions of cytokines and chemokines in human peripheral blood mononuclear cells (PBMC).
Human PBMCs isolated from three healthy donors were cultured (26106 cells/ml) with DH-PS (50 mg/ml) or PBS as control for 18 hrs. Supernatants
were harvested for the measurements of cytokines and chemokines. Y-axis represented the mean concentrations (Conc.) of cytokines/chemokines
with error bars showing the standard deviation of triplicate. Statistically significant difference: * compared with PBS-treated group, p,0.05. #
compared with PBS-treated group, p,0.005.
doi:10.1371/journal.pone.0094040.g003
DH-PS Induced IL-1ra Production in Monocyte
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induced higher IL-1ra mRNA expression than F3, which was
consistent with the ELISA data. On the other hand, F3 induced
larger amounts of IL-1b (366 pg/ml, ,52 fold increases of PBS
control) (Fig.S3) than DH-PS in human CD14+ cells (55, 24,
70 pg/ml for 3 healthy donors respectively, Fig.4). Taken
together, DH-PS-induced IL-1ra rise could over-ride IL1b-
induced activity far more effectively than F3.
Discussion
Dendrobium huoshanense (DH) is a versatile and valuable Chinese
herbal medicine that has been used for a long period of time in
China. The main bioactive molecules are polysaccharides and
alkaloids. Since it is highly valuable but rare, strategies have been
developed to enhance its growth and increases in polysaccharides
production [29]. Using crude extracts of polysaccharides isolated
from DH, we previously showed the in vitro induction of G-CSF
and a few other cytokines in mouse splenocytes [30]. Our present
study further extended the investigation to cover a comprehensive
panel of cytokines and chemokines induced by DH-PS in immune
cells of human in vitro and mouse in vivo. Our results clearly showed
that the administration of DH-PS in mice modulated immune
functions through modest activation and/or expansion of various
immune cells including NK cells/activated NK cells, NKT cells/
activated NKT cells, regulatory T cells, B cells/activated B cells,
CD4+ T cells/activated CD4+ T cells and CD8+ T cells/activated
CD8+ T cells. This was accompanied by the production of Th1
(IL-12 p40), Th2 cytokines (IL-6 and IL-10), chemokines (KC,
MCP-1, MIP-1b, RANTES) and inflammatory cytokines (TNF-a).
We also provided the first evidence that many cytokines and
chemokines were induced by DH-PS in human PBMC (IL-1a, IL-
1b, IL-12 p40, IL-6, IL-10, TNF-a, MIP-1a GM-CSF and IL-1ra)
Figure 4. DH-PS elicited the productions of cytokines and chemokines in human CD14+cells. Human CD14+cells isolated from three
healthy donors were cultured (16106 cells/ml) with DH-PS (50 mg/ml) or PBS as control for 18 hrs. Supernatants were harvested for the
measurements of cytokines and chemokines. Y-axis represented the mean concentrations (Conc.) of cytokines/chemokines with error bars showing
the standard deviation of triplicate. Statistically significant difference: * compared with PBS-treated group, p,0.05. # compared with PBS-treated
group, p,0.005.
doi:10.1371/journal.pone.0094040.g004
DH-PS Induced IL-1ra Production in Monocyte
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and monocytes (IL-1a, IL-1b, IL-12 p40, IL-6, IL-10, TNF-a,
RANTES, MCP-1, MIP-1a, GM-CSF and IL-1ra). Notably, both
IL-6 and IL-10 which have been shown to stimulate the
production of IL-1ra were also induced by DH-PS. These findings
were reminiscent of the potent immune-modulating effects
induced by Ganoderma lucidum (Reishi), another popular Chinese
herbal medicine. It was reported that polysaccharides isolated
from Ganoderma lucidum (Reishi) enhanced the proliferation of Con
A-stimulated mouse splenocytes [31]. We also showed that F3
stimulated the expansions of several types of immune cells
including regulatory T cells [32]. But unlike DH-PS, F3 appeared
to induce fewer regulatory T cells than DH-PS and larger amounts
of IFN-r and IL-12 p70 which were below the detection limit upon
the treatment with DH-PS, suggesting that DH-PS might exert
greater anti-inflammatory activities. Taken together, DH-PS
might exert its immune modulations not only by directly
stimulating cytokine secretions but also through promoting the
expansions and/or activations of immune cells.
Another important anti-inflammatory molecule found to be
induced by DH-PS was IL-1ra which was an acute phase protein
[33] and often elevated in the peripheral blood of patients with
sepsis [34], chronic rheumatic diseases [35,36,37] and following
surgical trauma [38,39]. The beneficial effects of IL-1ra on
inflammatory disorders had been demonstrated in many experi-
mental animal models of disease by administration of recombinant
IL-1ra [26,40,41]. In fact, recombinant IL-1ra had been in clinical
use for sepsis syndrome [42,43] and rheumatoid arthritis. Many
molecules including cytokines (IL-6 and IL-10, for example) and b-
glucans [26] which were the backbone components of the main
Figure 5. DH-PS induced IL-1ra production in vivo. BALB/c mice
(n = 3 for each group) were injected intraperitoneally with DH-PS (100
or 300 mg/mouse) or PBS only. Sera collected at 0 (before injection), 2
and 18 hours were used for the measurements of IL-1ra by ELISA assay.
Results were presented as mean concentrations with error bars showing
the standard deviation of three mice. Statistically significant difference:
* compared with PBS-treated group, p,0.05.
doi:10.1371/journal.pone.0094040.g005
Figure 6. DH-PS induced IL-1ra production in human PBMC, monocytes, but not neutrophils. (A) Human PBMCs were cultured
(26106 cells/ml) with increasing concentrations of DH-PS for 18 hrs and the supernatants were harvested for IL-1ra measurements. (B) Human
monocytes (CD14+ cells) were cultured (16106 cells/ml) with increasing concentrations of DH-PS for 18 hrs and the supernatants were harvested for
IL-1ra measurements. (C) Neutrophils were cultured (16105 cells/ml) with the increasing concentrations of DH-PS for 3 or 24 hours and supernatants
were harvested for IL-1ra measurements. Y-axis represented the mean concentration of IL-1ra (pg/ml). X-axis represented the concentration of DH-PS
(mg/ml). Concentration 0 represented the use of PBS only as vehicle control. Results were presented as mean values with error bars showing the
standard deviation of triplicate. Statistically significant difference: * compared with PBS-treated group, p,0.05. # compared with PBS-treated group,
p,0.005.
doi:10.1371/journal.pone.0094040.g006
DH-PS Induced IL-1ra Production in Monocyte
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bioactive polysaccharides of G. lucidum were reported to induce IL-
1ra production. Here, we demonstrated for the first time that DH-
PS induced the production of IL-1ra both in vivo and in vitro. The
rapid induction of IL-1ra by DH-PS in both mouse and human
suggested a direct stimulation by DH-PS. Many types of immune
cells were known to secrete IL-1ra including macrophages, mast
cells, neutrophils and monocytes, and our results showed that DH-
PS stimulated the production of IL-1ra in monocytes but not
neutrophils. We also found that unlike in vitro cell experiments, the
level of IL-1ra in sera declined rapidly at 18 hrs after the treatment
of DH-PS. This is consistent with the known short biological half-
life of IL-1ra in vivo with rapid renal clearance and excretion in the
urine [44]. In addition, DH-PS promoted THP-1 cell expansions
dose-dependently, suggesting that DH-PS might also stimulate the
proliferation of cells. Since certain glycans were the ligands for
Toll-Like Receptors (TLRs) which were important for the
activation of monocytes and involved in the transcription of IL-
1ra [25,45], it will be interesting to delineate whether and which
TLRs are the receptors for DH-PS in the future.
There were several intracellular signaling mechanism reported
to be involved in the regulation of IL-1ra expression. For
examples, NF-kB and C/EBP had been shown to be involved in
the expression of IL-1ra gene in hepatocytes [33], and MAPK
(ERK1/ERK2) was associated with the IL-1ra induction stimu-
lated by LPS [46,47]. Serine/threonine phosphatases also
participated in IL-1ra production when monocytes were contacted
by stimulated T cells [48]. In addition, STAT6 was involved in IL-
4 mediated IL-1ra production [49] and PI3K was reported to be
essential for the IFN-b-mediated IL-1ra production [50]. Our
results suggested that ERK/ELK, p38 MAPK, PI3K and NF-kB
were involved in DH-PS mediated production of IL-1ra since their
specific inhibitors decreased the expression of IL-1ra mRNA and
the IL-1ra production in protein level. Our results suggested
several possible signaling pathways involved in DH-PS-induced
IL-1ra secretion.
Ganoderma lucidum (Reishi) has been known for its benefits in
human health with the possession of anti-tumor and immune-
modulating activities [51,52,53,54]. The polysaccharides isolated
from Reishi were composed of a branched (1-.6)-b-D-glucan
moiety. The main structure of polysaccharides isolated from DH-
PS had been confirmed as acetylated glucomannan [30] which is
different from Reishi. The effects of Reishi on the immune system
had been attributed to cytokine inductions [55]. We compared the
cytokine profiles of human monocytes cultured with DH-PS or F3
and found that both DH-PS and F3 induced several cytokines and
chemokines including IL-1b, TNF-a, GM-CSF, IL-12 p40,
RANTES, MCP-1, MIP-1a, IL-6 and IL-10. However, IL-12
p70 and IFN-c were induced only by F3, suggesting a more TH1
bias activity of F3 compared with DH-PS since IL-12 p70 and
IFN-c had been reported to contribute to the differentiation of
type 1 T helper cell [56]. The ability of F3 to induce the
production of IL-1ra has also been reported [27]. However, we
found that DH-PS induced higher IL-1ra and lower IL-1b than F3
in human CD14+ cells and THP-1 cells Collectively, our findings
of lower levels of IL-12 p70, IFN-c, IL-1b, larger amounts of IL-
1ra and more regulatory T cells induced by DH-PS suggested that
DH-PS might possess better anti-inflammatory activities than F3.
Thus, DH-PS might be more potent than F3 for alleviation of
inflammatory disorders. Since the main structure of DH-PS had
been reported as acetylated glucomannan, it will be worthwhile to
Figure 7. DH-PS dose-dependently induced IL-1ra production in human monocytic cell line THP-1 cells. (A) THP-1 cells were cultured
with increasing concentrations of DH-PS at different cell densities for 18 hrs and supernatants were harvested for IL-1ra measurements. X-axis
represented the concentration of DH-PS (mg/ml). Concentration 0 represented the use of PBS only as vehicle control. (B) THP-1 cells were cultured
(26106 cells/ml) with DH-PS (100 mg/ml) or PBS and supernatants were collected in indicated time points for IL-1ra measurements. Results were
presented as mean values with error bars showing the standard deviation of triplicate. Statistically significant difference: * compared with PBS-treated
group, p,0.05. # compared with PBS-treated group, p,0.005. (C) THP-1 cells were cultured (26106 cells/ml) with DH-PS (100 mg/ml) and cells were
collected in indicated time points for the assessment of mRNA expression of IL-1ra by RT-PCR.
doi:10.1371/journal.pone.0094040.g007
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further identify the specific glycan moieties responsible for its anti-
inflammatory effects and its therapeutic potential in certain
immune disease models.
Materials and Methods
Ethics statement
Normal human blood was obtained from Taipei Blood Center
with the approval of the Human Subject Research Ethics
committee of both Academia Sinica and the Taiwan Blood
Services Foundation. All participants provided written informed
consent to Taipei Blood Services Foundation. All animal studies
were performed under the approved protocol
#TMIZ00JY2005158 by Institutional Animal Care and Utiliza-
tion Committee of Academia Sinica.
Preparations for crude polysaccharide extracts from
Dendrobium huoshanense (DH-PS)
The plant material of D. huoshanense was obtained from Yuen-
Foong-Yu Biotech Co. Taiwan [30]. Non-lignified primary
mucilage polysaccharides were collected from ground leaves and
stems at 4uC by dd-H2O extraction and the extracts were filtrated
to remove the insoluble parts. The dd-H2O extractions (DH-PS)
were dried for storage and resuspended in PBS before animal or
cell experiments.
Cell culture and reagents
Human peripheral blood mononuclear cells (PBMC) were
isolated from healthy donors by Ficoll-Paque PLUS (GE
Healthcare, Uppsala, Sweden) according to manufacturer’s
suggestions. CD14+ cells were further purified from PBMC by
anti-CD14 microbeads and magnetically activated cell sorting
(MACS) system (Miltenyi Biotech, Auburn, CA) according to
manufacturer’s instruction. PBMC and purified CD14+ cells
(purity .90%) were cultured in RPMI 1640 medium (Sigma-
Aldrich, USA) supplemented with 10% heat-inactivated Fetal
bovine serum (FBS) (Sigma-Aldrich, USA) and penicillin/strepto-
mycin (100 units/ml) (Invitrogen, CA, USA). For isolation of
neutrophils from healthy donors, leukocytes (including neutrophils
and PBMC) were separated from red blood cells (RBC) by
differential sedimentation using 1.5% dextran in PBS. Neutrophils
were separated from PBMC by Ficoll-Paque PLUS gradient
Figure 8. DH-PS induced IL-1ra production through MAPK, PI3K and NF-kB. (A) THP-1 cells (26106 cells/ml) were pretreated with the
indicated concentrations of inhibitors for various kinases including ERK/ELK, JNK, p38 MAPK, PI3K and NFkB (0.01, 0.1 and 1 mM, except for ERK and
PI3K: 0.1, 1 and 10 mM) or DMSO (0.1%) as control for 60 minutes and cultured with DH-PS (100 mg/ml) for another 18 hrs (B) Human CD14+ cells were
pretreated with the indicated concentrations of inhibitors or DMSO as control like (A) and cultured with DH-PS (100 mg/ml) for another 18 hrs.
Supernatants were harvested for IL-1ra measurements. Results were presented as fold of control (Y-axis) derived from the mean values of IL-1ra
concentrations of inhibitor-treated groups divided by DMSO control group and error bars showed the standard deviation of triplicate. Statistically
significant difference (Mean concentrations of IL-1ra were used for the comparisons): * compared with DMSO-treated group, p,0.05. # compared
with DMSO-treated group, p,0.005. (C) THP-1 cells (26106 cells/ml) were pretreated with inhibitors for ERK/ELK (10 mM), JNK (1 mM), p38 MAPK
(1 mM), PI3K (10 mM) and NFkB (1 mM) or DMSO (0.1%) as control and cultured with DH-PS (100 mg/ml) for another 12 hrs. Cells were collected for the
assessment of mRNA expression of IL-1ra.
doi:10.1371/journal.pone.0094040.g008
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method and further separated from the remaining RBC in the
pellet by hypotonic lysis method (purity.90%) [57]. THP-1 cells
(ATCC number: TIB-202) was maintained in RPMI 1640
supplemented with 10% FBS and penicillin/streptomycin
(100 units/ml). For experiments of cell signaling pathway,
inhibitors including PD98059, SP600125, SB203580, LY294002,
Helenalin and MG132 were purchased from Calbiochem (Merck
Millipore, Germany) and dissolved in dimethyl sulfoxide (DMSO)
(Sigma-Aldrich, USA) for cell experiments.
RNA isolation and RT-PCR
Total RNA was isolated by Trizol (Invitrogen, CA, USA)
according to manufacturer’s protocol. RNA (1 mg) was reverse-
transcribed to cDNA by ThermoScript RT-PCR system (Invitro-
gen, CA, USA). PCR was performed using Go Taq green master
mix (Promega, USA). Primers for IL-1ra: forward primer:
GGCCTCCGCAGTCACCTAATCACTCT, reverse primer:
TACTACTCG TCCTCCTGGAAGTAGAA. The PCR condi-
tions were as follows: 94uC for 1 minute followed by 35 cycles of
94uC for 1 minute, 58uC for 30 seconds, 72uC for 2 minutes and a
final step of 72uC for 10 minutes.
Animal experiments and flow cytometric analysis
Mice (Six-week-old female BALB/c, from National Laboratory
Animal Center, Taiwan) were injected intraperitoneally with DH-
PS (100 mg or 300 mg) in PBS or PBS only as control and
sacrificed at 72 hrs for the harvest of splenocytes. For flow
cytometric analysis, cells were resuspended in PBS (16106 cells/
ml) containing 2% FBS and 0.1% sodium azide (Sigma-Aldrich,
USA) and stained with cell surface markers including NK-
1.1+CD32 (NK cells), NK-1.1+CD32CD69+ (activated NK cells),
NK-1.1+CD3+ (NKT cells), NK-1.1+CD3+CD69+ (activated NKT
cells), Ly6G+ (granulocytes), CD11b+ (monocytes and macrophag-
es), CD11c+ (dendritic cells), CD11C+CD80+CD86+ (activated
dendritic cells), B220+CD23+ (B cells), B220+CD23+CD69+
(activated B cells), CD3+CD4+ (CD4+ T cells), CD3+CD4+CD69+
(activated CD4+ T cells), CD3+CD8+ (CD8+ T cells) and
CD3+CD8+CD69+ (activated CD8+ T cells). For the staining of
regulatory T cells (CD4+CD25+FOXP3+), cells were fixed with
4% paraformaldehyde (Sigma-Aldrich, USA) in PBS for 30
minutes at room temperature and permeabilized with 1% triton
x-100 (Sigma-Aldrich, USA) in PBS for another 30 minutes before
staining with characteristic markers for flow cytometric analysis.
After washing cells with PBS, cells were analyzed on FACS
Calibur (Becton Dickinson, San Jose, CA) with CellQuest
Figure 9. DH-PS induced more IL-1ra production than F3 in human CD14+ cells and THP-1 cells. (A) Human CD14+ cells isolated from one
healthy donor were cultured (26106 cells/ml) with increasing concentrations of DH-PS or F3 for 18 hours and supernatants were collected for the
measurements of IL-1ra. (B) Human CD14+ cells were cultured with DH-PS (100 mg/ml) or F3 (100 mg/ml) and supernatants were collected at the
indicated time points for IL-1ra measurements. (C) THP-1 cells were cultured (26106 cells/ml) with increasing concentrations of DH-PS or F3 for
18 hours and supernatants were collected for the measurements of IL-1ra. In A and C, X-axis represented the concentration of DH-PS (mg/ml).
Concentration 0 represented the use of PBS only as vehicle control. Results were presented as mean concentrations of IL-1ra with error bars showing
the standard deviation of triplicate. Statistically significant difference: * compared with F3-treated group, p,0.05.# compared with F3-treated group,
p,0.005. (D) THP-1 cells were cultured with DH-PS (100 mg/ml) or F3 (100 mg/ml) and cells were collected at the indicated time points for the
assessment of mRNA expression of IL-1ra.
doi:10.1371/journal.pone.0094040.g009
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software. Antibodies included PE-conjugated NK-1.1, Ly6G,
CD3, CD25, CD86, FITC-conjugated CD3, CD4, CD69,
CD80 and APC-conjugated CD11b, CD11c, Foxp3. All antibod-
ies were purchased from BD bioscience, USA.
Measurements of cytokines, chemokines and IL-1ra
To determine whether DH-PS changed the profiles of the
secretions of cytokines and/or chemokines in vivo, mouse sera
(obtained from facial vein blood sampling, Lancet) were collected
at 0 (before the injection), 2 and 18 hrs after the intraperitoneal
injection of DH-PS or PBS. Cytokines and chemokines were
quantified by the Beadlyte mouse 21-Plex Cytokine Detection
system (Millipore, Temecula, CA). For the detection of IL-1ra,
sera were quantified by Mouse IL-1ra/IL-1F3 Quantikine ELISA
Kit (R&D system, USA). To determine whether DH-PS changed
the profiles of the secretions of cytokines and/or chemokines in
human cells, cell culture supernatants were collected at 18 hrs after
DH-PS or PBS treatment. Cytokines and chemokines were
quantified by the Beadlyte human 22-Plex Cytokine Detection
system (Millipore, Temecula, CA). For the detection of IL-1ra,
supernatants were quantified by Human IL-1ra/IL-1F3 Quanti-
kine ELISA Kit (R&D system, USA). Beadlyte human 22-Plex
Cytokine Detection system included the measurements of IL-3, IL-
1a, IL-1b, IL-2, IL-12 p40, IL-12 p70, GM-CSF, IP-10, MCP-1,
MIP-1a, RANTES, TNF-a, IFN-c, IL-4, IL-5, IL-6, IL-7, IL-8,
IL-10, IL-13, IL-15 and Eotaxin. Beadlyte mouse 21-Plex
Cytokine Detection system included the measurements of IL-3,
IL-1a, IL-1b, IL-2, IL-12 p40, IL-12 p70, GM-CSF, KC, MCP-1,
MIP-1b, RANTES, TNF-a, IFN-c, IL-4, IL-5, IL-6, IL-9, IL-10,
IL-13, VEGF and IL-17.
Validation of viability or the proliferation of THP-1 cells
Cell viability and proliferation assays were determined by
adding MTS reagents to cell culture medium at 1:5 (v/v)
(Promega, USA) and incubating for another 1-4 hr as the
manufacturer’s suggestions. The results were observed through
the detection of the absorbance at 490 nm by spectrophotometer
(Molecular Devices, USA).
Statistical analysis
The Student’s t test was utilized to analyze the results of
cytokine and chemokine productions, cell numbers of subpopula-
tions of splenocytes, IL-1ra measurements, assays of the inhibitor-
treated cell viability and cell proliferation. For the determination
of statistical significance of results in Figure 8, S1 and S2, the mean
concentrations of IL1ra (pg/ml) (Fig.8) and mean values of
absorbance at 490 nm (Fig.S1, S2) were used to statistical analysis
before being converted to fold of control. P value was considered
to be significant at , 0.05. Data were expressed as the mean
values 6 standard deviation (S.D).
Supporting Information
Figure S1 Kinase inhibitors were not toxic to THP-1 cells in
indicated concentrations. Cells were cultured (26106 cells/ml)
with inhibitors for ERK/ELK (PD98059, 10 mM), JNK
(SP600125, 1 mM), p38 MAPK (SB203580, 1 mM), PI3K
(Ly294002, 10 mM), NFkB (Helenalin and MG132, 1 mM) or
DMSO (0.1%) as control for 18 hrs. Viability was determined by
MTS assay. Results were presented as fold of control (Y-axis)
derived from the mean values of absorbance at 490 nm of
inhibitor-treated groups divided by DMSO control group and
error bars showed the standard deviation of triplicate.
(TIF)
Figure S2 DH-PS promoted the proliferation of THP-1 cells.
THP-1 cells were cultured (26106 cells/ml) with increasing
concentrations of DH-PS or PBS (Concentration 0) for 18 hrs
and the proliferation rate was determined by MTS assay. X-axis
represented the concentration of DH-PS (mg/ml). Results were
presented as fold of control derived from the mean values of
absorbance at 490 nm of DH-PS-treated groups divided by PBS
control group and error bars showed the standard deviation of
triplicate. Statistically significant difference (Mean values of
absorbance were used for the comparisons): * compared with
PBS-treated group, p,0.05.
(TIF)
Figure S3 F3 elicited the productions of cytokines and
chemokines in human CD14+ cells. Human CD14+ cells isolated
from one healthy donor were cultured with F3 (50 mg/ml) or PBS
for 18 hrs and supernatants were collected for the measurements
of cytokines and chemokines. Y-axis represented the mean
concentrations (Conc.) of cytokines/chemokines with error bars
showing the standard deviation of triplicate. Statistically significant
difference: * compared with PBS-treated group, p,0.05. #
compared with PBS-treated group, p,0.005.
(TIF)
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